(Stockholm, Sweden, June 16, 2021) The first patient has been enrolled, on schedule, in ISAB's clinical trial of its aerosol generating system PreciseInhale®. CEO Manoush Masarrat: "Clinical validation of PreciseInhale® would be transformational for ISAB, opening up new markets and new opportunities for major growth."

On Wednesday 16 June, the first 4 healthy volunteer patients enrolled on the landmark clinical trial of PreciseInhale®. In total 12 patients will take part. The study aims to be finalized before the end of 2021. The study is being run by Clinical Trial Consultants AB (CTC), an award-winning CRO and clinical trial consultancy with extensive test facilities adjacent to Uppsala University Hospital.

Successful clinical validation would make PreciseInhale® the first aerosol generation platform that could be used from the drug discovery phase, through preclinical studies, all the way to phase I clinical trials in humans. This could significantly reduce translational errors between research stages, reducing risk, costs and accelerating drug development.

ISAB CEO Manoush Masarrat: "The clinical validation of PreciseInhale® will potentially open up new markets valued in the billions of SEK. It would significantly reduce drug development time for pharmaceutical companies, making PreciseInhale® the leading low-risk aerosol delivery system on the market."

For more information about Inhalation Sciences, please contact:

Manoush Masarrat, CEO

E-mail: Manoush.masarrat@inhalation.se

Mobile: +46 (0)73 628 9153

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company's patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.

https://news.cision.com/inhalation-sciences/r/inhalation-sciences--first-patient-enrolled-in-clinical-trial-of-preciseinhale,c3368468

https://mb.cision.com/Main/15842/3368468/1432841.pdf

(c) 2021 Cision. All rights reserved., source Press Releases - English